Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001808805-22-000093)

Filing Details

Accession Number:: 0001808805-22-000093
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-08-16 20:19:19
Reporting Period:: 2022-08-12

Accepted Time:: 2022-08-16 20:19:19
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1808805	Nautilus Biotechnology Inc.	NAUT	Laboratory Analytical Instruments (3826)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1865778	B. Matthew Murphy	C/O Nautilus Biotechnology, Inc. 2701 Eastlake Avenue East Seattle WA 98102	General Counsel	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-08-12	2,500	$2.85	46,640	No	4	P	Indirect	See Footnote
Common Stock	Acquisiton	2022-08-15	7,500	$2.84	54,140	No	4	P	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See Footnote
No	4	P	Indirect	See Footnote

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	1,250	Direct

Footnotes

Shares held by the Murphy Family Trust. The reporting person is the Trustee of the Murphy Family Trust.
1,250 shares of Common Stock acquired on June 1, 2022 through the Issuer's 2021 Employee Stock Purchase Plan.